SecBot SecBot
SC TO-T ·Filed Oct 21, 2026

CVAT

Cavitation Technologies, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5d 18h ago SEC0001683168-26-007992
Tender offer (third party)
Actionable Insight ▲ Bullish

The offer is fully funded with no financing contingency, and the board unanimously supports it, suggesting high completion probability. Key risks: CFIUS review (foreign acquirer), the cross-conditioned Alchemy tender (which could cause both to fail if Alchemy's fairness opinion triggers a price dispute), and the 90% minimum tender condition. Monitor the Alchemy fairness opinion (due ~Dec 24) and CFIUS clearance timeline. The final per-share price will be lower if warrants/convertibles are exercised before the Record Date.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+1d
CVAT ▲ 0.00% at T+1d
LONG call ✗ call lost 0.00% · α vs SPY +1.18% · entry $0.0400 → $0.0400
Next anchor: T+5d tomorrow
Latest observation: T+2 -28.63% FF3 residual α
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.18%
$0.0400
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

BrightFlixx Finance (Luxembourg) S.A. has commenced a cash tender offer to acquire all outstanding shares of Cavitation Technologies, Inc. (CVAT) at an initial estimated price of $0.106 per share, representing a ~232% premium to the last trading price of $0.03194. The offer is structured as a net aggregate price of $35 million less outstanding liabilities, divided by shares outstanding at the Record Date (Dec 24, 2026). Completion is contingent on a concurrent tender offer for Alchemy Beverages Inc. (where CVAT holds ~13.3%), CFIUS clearance, and a 90% minimum tender condition. The deal is funded entirely from Purchaser's existing cash with no financing condition.

Key Financial Metrics

Deal Value
$35.0M
Premium
232%
Deal Type
acquisition

Key Facts

  • BrightFlixx Finance (Luxembourg) S.A. offers to buy all CVAT shares for cash at a formula-based price: ($35M - liabilities) / shares outstanding at Record Date.
  • Initial estimated offer price is $0.106 per share, a ~232% premium to the $0.03194 closing price on Oct 16, 2026.
  • Offer period: Oct 20, 2026 to Jan 26, 2027 (65 business days), extendable to give shareholders 30 business days after Final Offer Price announcement.
  • Record Date for final price determination is Dec 24, 2026 (45 business days after commencement).
  • Conditions include: 90% minimum tender, concurrent Alchemy tender offer completion, CFIUS clearance, no material adverse effect, and director IP assignment/release.
  • Purchaser has $35M in cash available with no financing condition; funds will be deposited with Depositary (Dynamic Stock Transfer) before Expiration.
  • Company board unanimously recommends the offer; no shareholder vote required.
  • Post-closing: CVAT will be delisted from OTC Markets and deregistered under the Exchange Act.
  • As of Oct 16, 2026, there were 332,820,459 shares outstanding; outstanding liabilities were $738,000 as of Effective Date.
  • Outstanding warrants (31,571,784 shares) and convertible rights (1,250,000 shares) may be exercised before Record Date, potentially diluting the per-share price.

Financial Impact

Total consideration of $35 million in cash, less outstanding liabilities (~$738k), implying net ~$34.26M to shareholders. Initial estimated per-share price of $0.106 represents a ~232% premium to the $0.03194 pre-announcement close.

share pricemarket capitalizationdilution

Risk Factors

  • CFIUS review could block or delay the transaction given the foreign (Luxembourg) acquirer.
  • The concurrent Alchemy tender offer is a condition; if Alchemy's fairness opinion values it above $7M, Alchemy may seek a higher price, potentially derailing both offers.
  • 90% minimum tender condition may not be met if shareholders hold out for a higher price or prefer to remain invested.
  • Final per-share price is variable and could be lower than the initial estimate if liabilities increase or additional shares are issued via warrant/conversion exercises before the Record Date.
  • Post-closing, shares will be delisted and deregistered, eliminating any public market liquidity.

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC TO-T Filing (Primary)0001683168-26-007992
Document: brightflixx_exa1a.htm0001683168-26-007992
Document: brightflixx_exa1c.htm0001683168-26-007992
4 reports for CVAT
Performance horizon
33% Hit rate @ T+5 1 of 3 directional calls Went positive at some point 2 of 3 best @ T+20▲ +20.00%Sep 28, 2026
Filters
Rows
Reports for CVAT — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
SC TO-T
BULLISH ★ 7/10
$0.0400awaiting T+5—$0.0300 (−25.00%)
Oct 13, 2026
13d ago
8-K
BULLISH ★ 7/10
$0.0300 $0.0300· 0.00%▲ +1.15%$0.0300 (−0.00%)
Sep 28, 2026
28d ago
NT 10-K
BEARISH ★ 6/10
$0.0400 $0.0400· 0.00%▲ +1.20%$0.0300 (+25.00%)
Aug 19, 2026
9w ago
8-K
BULLISH ★ 7/10
$0.0400 $0.0443▲ +10.75%▲ +11.14%$0.0300 (−25.00%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 4h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026